pKLV2-U6gRNA3(BbsI)-PGKpuro2ABFP Citations (1)

Originally described in: A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia.
Tzelepis K, Koike-Yusa H, De Braekeleer E, Li Y, Metzakopian E, Dovey OM, Mupo A, Grinkevich V, Li M, Mazan M, Gozdecka M, Ohnishi S, Cooper J, Patel M, McKerrell T, Chen B, Domingues AF, Gallipoli P, Teichmann S, Ponstingl H, McDermott U, Saez-Rodriguez J, Huntly BJ, Iorio F, Pina C, Vassiliou GS, Yusa K Cell Rep. 2016 Oct 18;17(4):1193-1205. doi: 10.1016/j.celrep.2016.09.079. PubMed Journal

---

Articles Citing pKLV2-U6gRNA3(BbsI)-PGKpuro2ABFP

Articles

Comprehensive profiling of CRISPR/dCas9 epigenome editors indicates a complex link between on and off target effects. Pahlevan Kakhki M, Rangani F, Ewing E, Starvaggi Cucuzza C, Zheleznyakova G, Kalomoiri M, Kenny L, Raghavan A, Rao Prakash C, van den Hoeven G, Venkata S Badam T, Covacu R, Andreou I, Needhamsen M, Kular L, Jagodic M. Genome Biol. 2026 Jan 31;27(1):52. doi: 10.1186/s13059-026-03967-6. PubMed

If you have published an article using this material, please email us at to have your article added to this page.